Alcon's Irvine Operations Embrace Swiss Handover

Reed, Vita
August 2008
Orange County Business Journal;8/11/2008, Vol. 31 Issue 32, p1
The article reports on the ownership change undergone by eye device and drug maker Alcon Inc. in Irvine, California. Drug maker Novartis AG took a 25% stake in Alcon from majority owner Nestlé SA and is expected to buy Nestlé's remaining 52% stake for about $28 billion by 2011. Kenneth Lickel, an Alcon vice president who runs the company's Irvine Technology Center support the deal.


Related Articles

  • TALK OF NESTL INTEREST LIFTS L'ORAL SHARES. Groves, Ellen // WWD: Women's Wear Daily;4/7/2008, Vol. 195 Issue 74, p4 

    The article reports on the increase in shares of Nestlé after market speculation that the company could buy out L'Oreal. The speculation intensified after announcement that Nestlé will sell a 24.85 percent stake in its Alcon eye care business to health care company Novartis. According to a...

  • Novartis to close deal for full ownership of Alcon.  // Chain Drug Review;4/5/2010, Vol. 32 Issue 7, p31 

    The article reports that Novartis AG will gain full ownership of Alcon Inc. in New York City after completing the agreement with Nestlé SA to acquire a 77% majority stake of Alcon and entering into an all-share direct merger for the remaining 23%.

  • Deals roundup.  // Medical Device Daily;7/9/2008, Vol. 12 Issue 131, p9 

    The article offers news briefs concerning medical device company deals. Nestlé and Novartis reported the completion of their first-step purchase and sale of 74 million shares of Alcon eye care company, with Nestlé remaining as Alcon's majority shareholder with about 52% of its issued...

  • Massachusetts Plan Contests Alcon Buyout. Giardina, Michael // Investment Management Weekly;1/12/2010, p3 

    The article reports on the lawsuit filed by the Massachusetts Bricklayers and Mason Trust Funds against Alcon, Novartis and Nestl�. The lawsuit covers a new-pending offer which allegedly discriminates against minority shareholders. Based on court documents filed in the New York district...

  • Novartis Finalizes Alcon Acquisition.  // Review of Optometry;1/15/2011, Vol. 148 Issue 1, p8 

    The article reports on the move of the pharmaceutical company Novartis AG to acquire the eye care firm Alcon Inc. through purchasing its remaining publicly traded shares in the U.S.

  • Novartis sets its sights on Alcon.  // Medical Marketing & Media;Feb2010, Vol. 45 Issue 2, p11 

    The article reports on the bid of Novartis AG for full ownership of Alcon Inc. which has an eye care consumer product unit worth one billion dollars.

  • CORPORATE.  // MondayMorning;1/11/2010, Vol. 18 Issue 1, p2 

    The article offers news briefs related to business enterprises in the U.S. Novartis AG offers to buy the Alcon Inc. from the Nestle SA and minority shareholders for 39.3 billion to extend its eye surgery. Great Britain-based AstraZeneca Plc reach a deal with Teva Pharmaceutical Industries Ltd....

  • Binge benefits. Day, Julia // Marketing Week;7/29/1999, Vol. 22 Issue 26, p24 

    Focuses on the effort of food and pharmaceutical companies in Great Britain to produce functional foods. Nestle's launch of LC1 yogurt, yogurt-style deserts and LC1 Go milk drink; Novartis' offering of healthy products like vitamins, slimming drinks and meal replacements.

  • Novartis sells off Gerber. Gibson, Jane; Bains, Elizabeth // ICIS Chemical Business;4/16/2007, Vol. 2 Issue 62, p10 

    The article reports on the decision of Novartis to sell its Gerber baby food business to Nestle for $5.5 billion. The sale brings an end to the company's divestment program, following its strategy to focus on healthcare. Novartis has appointed Joseph Jimenez as the chief executive officer (CEO)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics